Prospective molecular biological and serological examination for the detection of SARS-CoV-2 (COVID-19) in employees of a hospital of regular care in Germany

• Conditions: U07.1; COVID-19, virus identified

• Registration Number: DRKS00021270
• Lead Sponsor: Krankenhaus Reinbek St. Adolf-Stift

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-04-15
• Results First Posted: 2020-10-10
• Study Completion: 2022-05-20
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 871

Inclusion Criteria

Actually working in the study center

Exclusion Criteria

No informed consent

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
How many employees develop a COVID-19 positive test and how many develop antibodies in the sense of a seroconversion?

Secondary Outcome Measures

Name	Time	Method
Correlation between symptoms and positive test results<br>Do certain groups show certain symptoms and certain courses?